Literature DB >> 25542604

Effect of low-level laser therapy on adolescents with temporomandibular disorder: a blind randomized controlled pilot study.

Camila Haddad Leal de Godoy1, Lara Jansiski Motta2, Kristianne Porta Santos Fernandes3, Raquel Agnelli Mesquita-Ferrari3, Alessandro Melo Deana4, Sandra Kalil Bussadori5.   

Abstract

PURPOSE: The aim of this pilot study was to evaluate the effect of low-level laser therapy on pain, mandibular movements, and occlusal contacts in adolescents and young adults with temporomandibular disorder.
MATERIALS AND METHODS: Individuals aged 14 to 23 years were evaluated. The Research Diagnostic Criteria for Temporomandibular Disorders were used for the diagnosis of temporomandibular disorders. Pain was assessed with a visual analog scale. Occlusal contacts were recorded using the T-Scan III program (Tekscan, Boston, MA). The participants were randomly allocated to 2 groups: active or placebo laser treatment. The laser parameters were as follows: wavelength of 780 nm, energy density of 33.5 J/cm(2), power of 50 mW, power density of 1.67 W/cm(2), and 20-second exposure time. The Kolmogorov-Smirnov test was used to determine the normality of the data distribution. The paired t test was used for the comparisons of the pretreatment and post-treatment results. The SPSS program for Windows (version 15.0; SPSS, Chicago, IL) was used for all analyses, with the level of significance set at 5% (P < .05).
RESULTS: No statistically significant differences between groups were found for the right and left anterior temporal muscles (P = .3801 and P = .5595, respectively), superior masseter muscles (P = .087 and P = .1969, respectively), medial masseter muscles (P = .2241 and P = .076, respectively), or inferior masseter muscles (P = .5589 and P = .3268, respectively) after treatment.
CONCLUSIONS: No statistically significant differences were found regarding pain, mandibular range of motion, or the distribution of occlusal contacts after treatment with low-level laser therapy. These preliminary results need to be verified in a larger sample of patients to confirm the lack of response to low-level laser therapy.
Copyright © 2015 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25542604     DOI: 10.1016/j.joms.2014.09.018

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  10 in total

1.  Simultaneous red and infrared light-emitting diodes reduced pain in individuals with temporomandibular disorder: a randomized, controlled, double-blind, clinical trial.

Authors:  Dowglas Fernando Magalhães de Sousa; Tainá Caroline Dos Santos Malavazzi; Alessandro Melo Deana; Anna Carolina Ratto Tempestini Horliana; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori; Raquel Agnelli Mesquita-Ferrari
Journal:  Lasers Med Sci       Date:  2022-06-24       Impact factor: 3.161

Review 2.  Low-level laser therapy in temporomandibular joint disorders: a systematic review.

Authors:  Syed Ansar Ahmad; Shamimul Hasan; Shazina Saeed; Ateeba Khan; Munna Khan
Journal:  J Med Life       Date:  2021 Mar-Apr

3.  Administration of low-level laser on muscles of mastication following the induction of initial fatigue: protocol for a randomized, controlled, clinical trial.

Authors:  Greice de Brito Bitencourt; Marcela Leticia Leal Gonçalves; Fernanda Yukie Kobayashi; Lara Jansiski Motta; Daniela Fátima Teixeira da Silva; Fabiano Politti; Leandro Paulino Feliciano; Raquel Agnelli Mesquita-Ferrari; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

4.  Photobiomodulation with simultaneous use of red and infrared light emitting diodes in the treatment of temporomandibular disorder: study protocol for a randomized, controlled and double-blind clinical trial.

Authors:  Dowglas Fernando Magalhães de Sousa; Marcela Letícia Leal Gonçalves; Fabiano Politti; Renan Didier de Paula Lovisetto; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori; Raquel Agnelli Mesquita-Ferrari
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Effectiveness of low-level gallium aluminium arsenide laser therapy for temporomandibular disorder with myofascial pain: A systemic review and meta-analysis.

Authors:  Xuelian Wu; Jiang Zhu; Bing Zheng; Jie Liu; Zonghui Wu
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

6.  Nonpharmacological Interventions for Pain in Patients with Temporomandibular Joint Disorders: A Systematic Review.

Authors:  Liliana Argueta-Figueroa; Luis Angel Flores-Mejía; Beatriz Xóchitl Ávila-Curiel; Blanca Irma Flores-Ferreyra; Rafael Torres-Rosas
Journal:  Eur J Dent       Date:  2022-03-08

7.  Laser phototherapy in acute posttraumatic trismus - Case-series study.

Authors:  Emilia Rasca; Amaury Namour; Aude Fauchon-Giumelli; Samir Nammour
Journal:  Laser Ther       Date:  2018-09-30

Review 8.  Photobiomodulation and myofascial temporomandibular disorder: Systematic review and meta-analysis followed by cost-effectiveness analysis.

Authors:  Ana-Paula-Taboada Sobral; Sergio-de Sousa Sobral; Thalita-Molinos Campos; Anna-Carolina-Ratto-Tempestini Horliana; Kristianne-Porta-Santos Fernandes; Sandra-Kalil Bussadori; Lara-Jansiski Motta
Journal:  J Clin Exp Dent       Date:  2021-07-01

9.  Electromyographic evaluation of a low-level laser protocol for the treatment of temporomandibular disorder: a randomized, controlled, blind trial.

Authors:  Camila Haddad Leal de Godoy; Lara Jansiski Motta; Eugenio Jose Garcia; Kristianne Porta Santos Fernandes; Raquel Agnelli Mesquita-Ferrari; Ravana Angelini Sfalcin; Pamella de Barros Motta; Fabiano Politti; Sandra Kalil Bussadori
Journal:  J Phys Ther Sci       Date:  2017-12-07

Review 10.  Temporomandibular Disorders: "Occlusion" Matters!

Authors:  Robert J A M de Kanter; Pasquale G F C M Battistuzzi; Gert-Jan Truin
Journal:  Pain Res Manag       Date:  2018-05-15       Impact factor: 3.037

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.